MRVIMaravai LifeSciences Holdings, Inc.
4.770USD-2.15%Mkt Cap: 1.76B USDP/E: Last update: 2026-06-01

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the…

Indicators:|

Key Statistics

Company
Market Cap1.76B USD
Enterprise Value1.01B USD
Revenue (TTM)204.73M USD
Gross Profit33.99M USD
Net Income (TTM)-130.77M USD
Revenue/Share1.411 USD
Last Price4.770 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees416
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-46.26
PEG
EV/EBITDA-26.68
EV/Revenue4.96
P/S8.65
P/B3.35
EPS (TTM)-0.71
EPS (Forward)-0.10
52W Range
1.99093% of range4.995
52W High4.995 USD
52W Low1.990 USD
Profitability
Gross Margin18.30%
Oper. Margin1.09%
EBITDA Margin-18.57%
Profit Margin-70.41%
ROE-61.58%
ROA-16.97%
Growth
Revenue Growth40.50%
Earnings Growth
Cash Flow & Leverage
Operating CF-57.57M USD
CapEx (TTM)13.15M USD
FCF Margin-5.54%
FCF Yield-0.64%
Net Debt149.11M USD
Net Debt/EBITDA-3.92
Balance Sheet
Debt/Equity1.72
Current Ratio5.91
Quick Ratio4.68
Book Value/Sh1.434 USD
Cash/Share1.125 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating
Target (Mean)5.700 USD
Target Range5.000 USD6.000 USD
# Analysts5
Ownership
Shares Out.147.51M
Float102.60M
Insiders13.75%
Institutions88.42%
Short Interest
Short Ratio3.4d
Short % Float6.85%
Short % Out.5.77%
Shares Short8.51M
Short (prev mo.)9.24M
Technical
SMA 503.625 (+31.6%)
SMA 2003.324 (+43.5%)
Beta0.62
S&P 52W Chg27.94%
Avg Vol (30d)2.35M
Avg Vol (10d)2.52M
Technical Indicators
RSI (14)69.5
MACD0.2648
MACD Signal0.2492
MACD Hist.+0.0156
BB Upper5.015 USD
BB Middle4.315 USD
BB Lower3.616 USD
BB Width32.44%
ATR (14)0.2528 USD
Vol Ratio (20d)0.71x